Company Coverage
CP Axtra (CPAXT TB): Acquisition Of The Food Purveyor
HOLD (Maintained)
Current price:
Target price:
Upside:
Bt14.60
Bt14.50
-0.68%
Analyst
Highlights
- The acquisition of The Food Purveyor was completed on 1 Sep 26. We are neutral on the deal, which will lift 2027 earnings by only 1-2%. Balance sheet impact should be limited, with net IBD/E remaining at 0.4x.
- The Happitat stands out with its unique place of happiness concept, but its challenge is the lack of tenants capable of generating traffic.
- Maintain HOLD with a target price of Bt14.50. 3Q26 earnings are expected to decline yoy, before recovering in 4Q26 on a low base last year.
Analysis
- The acquisition of The Food Purveyor was completed on 1 Sep 26. CP Axtra (CPAXT) announced the 100% acquisition of The Food Purveyor (TFP) through Lotus Stores (Malaysia) was completed on 1 Sep 26.
- Nature of business. TFP operates premium supermarkets in Malaysia under Village Grocer, B.I.G., BSC Fine Foods, OTK and The Food Merchant, with over 50 stores and around 30% market share.
- Narrative. The acquisition allows CPAXT to enter the premium supermarket segment, which is growing at about 10% CAGR versus around 4% for overall retail, while leveraging TFP’s expertise and stronger sales growth to enhance CPAXT’s existing businesses.
- Transaction value. CPAXT acquired 100% of TFP for Rm1,597m (Bt13.1b), funded externally, including 80% through Malaysian bank loans.
- No material financial impact. CPAXT will consolidate TFP since 1 Sep 26, but we expect transaction-related expenses and interest costs to result in a net loss contribution in 3Q26. Management expects the deal to become net accretive from 2027, supported by TFP’s revenue growth above the about 10% market rate which will contribute 4% to CPAXT’s retail revenue, a higher gross margin than Lotus’s Malaysia and higher EBIT margin than CPAXT’s existing retail business. However, assuming a 4.5% financing cost, we estimate the deal will lift 2027 earnings by only 1-2%. Balance sheet impact should be limited, with assets increasing by around Bt4b and net IBD/E remaining at around 0.4x. Overall, we view the deal as neutral and remain in a wait-and-see stance, with future upside dependent on the realisation of sales, margin and operational synergies.
Highlights
- The acquisition of The Food Purveyor was completed on 1 Sep 26. We are neutral on the deal, which will lift 2027 earnings by only 1-2%. Balance sheet impact should be limited, with net IBD/E remaining at 0.4x.
- The Happitat stands out with its unique place of happiness concept, but its challenge is the lack of tenants capable of generating traffic.
- Maintain HOLD with a target price of Bt14.50. 3Q26 earnings are expected to decline yoy, before recovering in 4Q26 on a low base last year.
Analysis
- The acquisition of The Food Purveyor was completed on 1 Sep 26. CP Axtra (CPAXT) announced the 100% acquisition of The Food Purveyor (TFP) through Lotus Stores (Malaysia) was completed on 1 Sep 26.
- Nature of business. TFP operates premium supermarkets in Malaysia under Village Grocer, B.I.G., BSC Fine Foods, OTK and The Food Merchant, with over 50 stores and around 30% market share.
- Narrative. The acquisition allows CPAXT to enter the premium supermarket segment, which is growing at about 10% CAGR versus around 4% for overall retail, while leveraging TFP’s expertise and stronger sales growth to enhance CPAXT’s existing businesses.
- Transaction value. CPAXT acquired 100% of TFP for Rm1,597m (Bt13.1b), funded externally, including 80% through Malaysian bank loans.
- No material financial impact. CPAXT will consolidate TFP since 1 Sep 26, but we expect transaction-related expenses and interest costs to result in a net loss contribution in 3Q26. Management expects the deal to become net accretive from 2027, supported by TFP’s revenue growth above the about 10% market rate which will contribute 4% to CPAXT’s retail revenue, a higher gross margin than Lotus’s Malaysia and higher EBIT margin than CPAXT’s existing retail business. However, assuming a 4.5% financing cost, we estimate the deal will lift 2027 earnings by only 1-2%. Balance sheet impact should be limited, with assets increasing by around Bt4b and net IBD/E remaining at around 0.4x. Overall, we view the deal as neutral and remain in a wait-and-see stance, with future upside dependent on the realisation of sales, margin and operational synergies.
HOLD (Maintained)
Current price:
Target price:
Upside:
Bt14.60
Bt14.50
-0.68%
Analyst
IMPORTANT NOTICE - DISCLOSURES AND DISCLAIMERS
This report is provided subject to, and must be read together with, the full Disclosures / Disclaimers available at this link, which are incorporated by reference into this report. In particular, this report is intended for general circulation and informational purposes only and does not constitute personal investment advice or a recommendation to buy or sell any investment product or security. You should independently evaluate the information and, where necessary, seek advice from a qualified financial adviser regarding the suitability of any investment. Analyst certifications required under applicable regulations, including SEC Regulation AC (where relevant), are included in this report. By accessing, receiving or using this report, you acknowledge that you have read, understood and agreed to be bound by the Disclosures / Disclaimers, as may be amended, supplemented or updated from time to time.